Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lyrica be taken with a weight loss program?How does aurobindo ensure quality in clonazepam synthesis?How does tigecycline's patent extension affect cost?What role do insurers play in setting lipitor's generic price?Can lipitor be prescribed for reducing processed food cravings?
See the DrugPatentWatch profile for remicade
Remicade (infliximab) is used to treat several autoimmune and inflammatory diseases where tumor necrosis factor (TNF) drives ongoing inflammation. It’s prescribed for adults and some children for conditions including: - Rheumatoid arthritis (RA) - Psoriatic arthritis - Ankylosing spondylitis - Crohn’s disease - Ulcerative colitis It may also be used for other TNF-driven inflammatory conditions depending on country-specific prescribing guidance.
Remicade is generally considered when: - Symptoms are moderate to severe, or - Other treatments haven’t worked well enough, or - The disease is active and needs strong anti-inflammatory control. In some cases, doctors use Remicade with other medicines (such as methotrexate for rheumatoid arthritis) to improve control and reduce immune reactions.
Remicade is a TNF blocker (anti-TNF therapy). By neutralizing TNF, it reduces inflammation and helps lower immune-driven tissue damage in diseases like RA, Crohn’s, and ulcerative colitis.
Anti-TNF drugs like Remicade can increase susceptibility to certain infections, including reactivation of latent tuberculosis. Patients are typically screened for TB and other infection risks before starting therapy, and they’re monitored during treatment.
Other Questions About Remicade :